BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6212126)

  • 1. Suppressor cells as an agent of immune facilitation. II. Adoptive transfer of passively induced enhancement of allografted tumors.
    Douvas GS; Kinsky RG; Duc HT; Voisin GA
    Cell Immunol; 1982 Apr; 68(2):389-401. PubMed ID: 6212126
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of suppressor cells in active enhancement of allografted tumors. In vivo (adoptive transfer) and in vitro (MLR) evaluation. Synergy with enhancing antibodies.
    Kinsky RG; Duc HT; Chaouat G; Voisin GA
    Cell Immunol; 1981 Feb; 58(1):107-23. PubMed ID: 6452950
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 4. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of immunological enhancement.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
    Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preferential efficicacy of immunocomplexes in the facilitation of tumor allografts].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1973 Nov; 124(4):567-72. PubMed ID: 4134880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of cyclophosphane on the suppressor activity of spleen cells in mice with transplantable tumors].
    Kovbasiuk SA; Iudin VM; Kushko LIa; Semenova-Kobzar' RA
    Eksp Onkol; 1985; 7(5):60-3. PubMed ID: 2933244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of suppressor cells in neonatally induced tolerance to transplantable hepatoma 22A].
    Nikonova MF; Maĭskiĭ IN; Pokrovskaia TA; Demeshina IV
    Biull Eksp Biol Med; 1980 Oct; 90(10):464-5. PubMed ID: 6448640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete in vivo destruction of allografted sarcoma I cells by circulating antibodies.
    Kinsky R; Chouroulinkov I; Voisin GA
    Transplantation; 1970 Nov; 10(5):450-1. PubMed ID: 5490529
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative studies on tumor enhancement in mice. I. Enhancement of sarcoma I induced by IgM, IgG1, and IgG2.
    Rubinstein P; Decary F; Streun EW
    J Exp Med; 1974 Aug; 140(2):591-6. PubMed ID: 4846488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rat tumor allografts on the blood level of passively transferred alloantibodies.
    Buchsbaum DJ
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1197-201. PubMed ID: 4112429
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of suppressor cells and allograft tolerance.
    Brent L; Horsburgh T; Wood PJ
    Transplant Proc; 1980 Sep; 12(3):464-72. PubMed ID: 6452724
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory mechanisms of cell-mediated immunity in allogeneic pregnancy.
    Chaouat G; Monnot P; Hoffman M; Chaffaux S
    Am J Reprod Immunol (1980); 1980; 1(1):18-22. PubMed ID: 6461264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor cells in transplantation tolerance. II. maturation of suppressor cells in the bone marrow chimera.
    Tutschka PJ; Ki PF; Beschorner WE; Hess AD; Santos GW
    Transplantation; 1981 Oct; 32(4):321-5. PubMed ID: 6460354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-antibody interactions in immunological enhancement.
    Takasugi M; Hildemann WH
    Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological specificity and the kinetics of T-suppressor induction in the immunization of mice with allogeneic spleen].
    Brondz BD; Karaulov AV; Abronina IF
    Tsitologiia; 1980 May; 22(5):583-90. PubMed ID: 6449100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are DST/allograft-induced suppressor cells donor specific?
    Wakely E; Cutkomp J; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):488-90. PubMed ID: 2523147
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-specific active enhancement of a murine sarcoma.
    Bloom ET; Hildemann WH
    Tissue Antigens; 1971; 1(1):5-13. PubMed ID: 5154368
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific adoptive and passive immunotherapy be parabiosis for syngeneic mouse and rat tumors.
    Southam CM; Bower EB; Currie VE; Babcock VI
    Ann N Y Acad Sci; 1976; 277(00):505-15. PubMed ID: 1069559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.